▶ 調査レポート

間欠的発熱症候群の世界市場（～2026年）
• 英文タイトル：Global Periodic Fever Syndrome Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。間欠的発熱症候群の世界市場（～2026年） / Global Periodic Fever Syndrome Market Size, Status and Forecast 2020-2026 / MRC2-11QY04216資料のイメージです。• レポートコード：MRC2-11QY04216
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Multi User￥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料は間欠的発熱症候群のグローバル市場について調査・分析したレポートです。種類別（高IGE D症候群、家族性地中海熱症候群、TNF受容体関連周期症候群、クリオピリン関連周期症候群、その他）市場規模、用途別（病院、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別間欠的発熱症候群の競争状況、市場シェア
・世界の間欠的発熱症候群市場：種類別市場規模 2015年-2020年（高IGE D症候群、家族性地中海熱症候群、TNF受容体関連周期症候群、クリオピリン関連周期症候群、その他）
・世界の間欠的発熱症候群市場：種類別市場規模予測 2021年-2026年（高IGE D症候群、家族性地中海熱症候群、TNF受容体関連周期症候群、クリオピリン関連周期症候群、その他）
・世界の間欠的発熱症候群市場：用途別市場規模 2015年-2020年（病院、小売薬局）
・世界の間欠的発熱症候群市場：用途別市場規模予測 2021年-2026年（病院、小売薬局）
・北米の間欠的発熱症候群市場分析：米国、カナダ
・ヨーロッパの間欠的発熱症候群市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの間欠的発熱症候群市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の間欠的発熱症候群市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの間欠的発熱症候群市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Novartis、Simvastatin、Merck、Swedish Orphan Biovitrum
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Periodic fever syndrome are a set of disorders characterized by recurrent episodes of systemic and organ-specific inflammation.
The syndromes are diverse, but tend to cause episodes of fever, joint pains, skin rashes, abdominal pains and may lead to chronic complications such as amyloidosis.

Market Analysis and Insights: Global Periodic Fever Syndrome Market
The global Periodic Fever Syndrome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Periodic Fever Syndrome Scope and Market Size
Periodic Fever Syndrome market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Periodic Fever Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Novartis
Simvastatin
Merck
Swedish Orphan Biovitrum
…

Market segment by Type, the product can be split into
Hyperimmunoglobulinemia D Syndrome
Familial Mediterranean Fever Syndrome
TNF Receptor-Associated Periodic Syndrome
Cryopyrin-Associated Periodic Syndrome
Others
Market segment by Application, split into
Hospitals
Retail Pharmacy

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Periodic Fever Syndrome Revenue
1.4 Market by Type
1.4.1 Global Periodic Fever Syndrome Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hyperimmunoglobulinemia D Syndrome
1.4.3 Familial Mediterranean Fever Syndrome
1.4.4 TNF Receptor-Associated Periodic Syndrome
1.4.5 Cryopyrin-Associated Periodic Syndrome
1.4.6 Others
1.5 Market by Application
1.5.1 Global Periodic Fever Syndrome Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Retail Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Periodic Fever Syndrome Market Perspective (2015-2026)
2.2 Global Periodic Fever Syndrome Growth Trends by Regions
2.2.1 Periodic Fever Syndrome Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Periodic Fever Syndrome Historic Market Share by Regions (2015-2020)
2.2.3 Periodic Fever Syndrome Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Periodic Fever Syndrome Market Growth Strategy
2.3.6 Primary Interviews with Key Periodic Fever Syndrome Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Periodic Fever Syndrome Players by Market Size
3.1.1 Global Top Periodic Fever Syndrome Players by Revenue (2015-2020)
3.1.2 Global Periodic Fever Syndrome Revenue Market Share by Players (2015-2020)
3.1.3 Global Periodic Fever Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Periodic Fever Syndrome Market Concentration Ratio
3.2.1 Global Periodic Fever Syndrome Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Periodic Fever Syndrome Revenue in 2019
3.3 Periodic Fever Syndrome Key Players Head office and Area Served
3.4 Key Players Periodic Fever Syndrome Product Solution and Service
3.5 Date of Enter into Periodic Fever Syndrome Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Periodic Fever Syndrome Historic Market Size by Type (2015-2020)
4.2 Global Periodic Fever Syndrome Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Periodic Fever Syndrome Market Size by Application (2015-2020)
5.2 Global Periodic Fever Syndrome Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Periodic Fever Syndrome Market Size (2015-2020)
6.2 Periodic Fever Syndrome Key Players in North America (2019-2020)
6.3 North America Periodic Fever Syndrome Market Size by Type (2015-2020)
6.4 North America Periodic Fever Syndrome Market Size by Application (2015-2020)

7 Europe
7.1 Europe Periodic Fever Syndrome Market Size (2015-2020)
7.2 Periodic Fever Syndrome Key Players in Europe (2019-2020)
7.3 Europe Periodic Fever Syndrome Market Size by Type (2015-2020)
7.4 Europe Periodic Fever Syndrome Market Size by Application (2015-2020)

8 China
8.1 China Periodic Fever Syndrome Market Size (2015-2020)
8.2 Periodic Fever Syndrome Key Players in China (2019-2020)
8.3 China Periodic Fever Syndrome Market Size by Type (2015-2020)
8.4 China Periodic Fever Syndrome Market Size by Application (2015-2020)

9 Japan
9.1 Japan Periodic Fever Syndrome Market Size (2015-2020)
9.2 Periodic Fever Syndrome Key Players in Japan (2019-2020)
9.3 Japan Periodic Fever Syndrome Market Size by Type (2015-2020)
9.4 Japan Periodic Fever Syndrome Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Periodic Fever Syndrome Market Size (2015-2020)
10.2 Periodic Fever Syndrome Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Periodic Fever Syndrome Market Size by Type (2015-2020)
10.4 Southeast Asia Periodic Fever Syndrome Market Size by Application (2015-2020)

11 India
11.1 India Periodic Fever Syndrome Market Size (2015-2020)
11.2 Periodic Fever Syndrome Key Players in India (2019-2020)
11.3 India Periodic Fever Syndrome Market Size by Type (2015-2020)
11.4 India Periodic Fever Syndrome Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Periodic Fever Syndrome Market Size (2015-2020)
12.2 Periodic Fever Syndrome Key Players in Central & South America (2019-2020)
12.3 Central & South America Periodic Fever Syndrome Market Size by Type (2015-2020)
12.4 Central & South America Periodic Fever Syndrome Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Periodic Fever Syndrome Introduction
13.1.4 Novartis Revenue in Periodic Fever Syndrome Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Simvastatin
13.2.1 Simvastatin Company Details
13.2.2 Simvastatin Business Overview
13.2.3 Simvastatin Periodic Fever Syndrome Introduction
13.2.4 Simvastatin Revenue in Periodic Fever Syndrome Business (2015-2020)
13.2.5 Simvastatin Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Periodic Fever Syndrome Introduction
13.3.4 Merck Revenue in Periodic Fever Syndrome Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Swedish Orphan Biovitrum
13.4.1 Swedish Orphan Biovitrum Company Details
13.4.2 Swedish Orphan Biovitrum Business Overview
13.4.3 Swedish Orphan Biovitrum Periodic Fever Syndrome Introduction
13.4.4 Swedish Orphan Biovitrum Revenue in Periodic Fever Syndrome Business (2015-2020)
13.4.5 Swedish Orphan Biovitrum Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Periodic Fever Syndrome Key Market Segments
Table 2. Key Players Covered: Ranking by Periodic Fever Syndrome Revenue
Table 3. Ranking of Global Top Periodic Fever Syndrome Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Periodic Fever Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hyperimmunoglobulinemia D Syndrome
Table 6. Key Players of Familial Mediterranean Fever Syndrome
Table 7. Key Players of TNF Receptor-Associated Periodic Syndrome
Table 8. Key Players of Cryopyrin-Associated Periodic Syndrome
Table 9. Key Players of Others
Table 10. Global Periodic Fever Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Periodic Fever Syndrome Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Periodic Fever Syndrome Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Periodic Fever Syndrome Market Share by Regions (2015-2020)
Table 14. Global Periodic Fever Syndrome Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Periodic Fever Syndrome Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Periodic Fever Syndrome Market Growth Strategy
Table 20. Main Points Interviewed from Key Periodic Fever Syndrome Players
Table 21. Global Periodic Fever Syndrome Revenue by Players (2015-2020) (Million US$)
Table 22. Global Periodic Fever Syndrome Market Share by Players (2015-2020)
Table 23. Global Top Periodic Fever Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Periodic Fever Syndrome as of 2019)
Table 24. Global Periodic Fever Syndrome by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Periodic Fever Syndrome Product Solution and Service
Table 27. Date of Enter into Periodic Fever Syndrome Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Periodic Fever Syndrome Market Size by Type (2015-2020) (Million US$)
Table 30. Global Periodic Fever Syndrome Market Size Share by Type (2015-2020)
Table 31. Global Periodic Fever Syndrome Revenue Market Share by Type (2021-2026)
Table 32. Global Periodic Fever Syndrome Market Size Share by Application (2015-2020)
Table 33. Global Periodic Fever Syndrome Market Size by Application (2015-2020) (Million US$)
Table 34. Global Periodic Fever Syndrome Market Size Share by Application (2021-2026)
Table 35. North America Key Players Periodic Fever Syndrome Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Periodic Fever Syndrome Market Share (2019-2020)
Table 37. North America Periodic Fever Syndrome Market Size by Type (2015-2020) (Million US$)
Table 38. North America Periodic Fever Syndrome Market Share by Type (2015-2020)
Table 39. North America Periodic Fever Syndrome Market Size by Application (2015-2020) (Million US$)
Table 40. North America Periodic Fever Syndrome Market Share by Application (2015-2020)
Table 41. Europe Key Players Periodic Fever Syndrome Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Periodic Fever Syndrome Market Share (2019-2020)
Table 43. Europe Periodic Fever Syndrome Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Periodic Fever Syndrome Market Share by Type (2015-2020)
Table 45. Europe Periodic Fever Syndrome Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Periodic Fever Syndrome Market Share by Application (2015-2020)
Table 47. China Key Players Periodic Fever Syndrome Revenue (2019-2020) (Million US$)
Table 48. China Key Players Periodic Fever Syndrome Market Share (2019-2020)
Table 49. China Periodic Fever Syndrome Market Size by Type (2015-2020) (Million US$)
Table 50. China Periodic Fever Syndrome Market Share by Type (2015-2020)
Table 51. China Periodic Fever Syndrome Market Size by Application (2015-2020) (Million US$)
Table 52. China Periodic Fever Syndrome Market Share by Application (2015-2020)
Table 53. Japan Key Players Periodic Fever Syndrome Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Periodic Fever Syndrome Market Share (2019-2020)
Table 55. Japan Periodic Fever Syndrome Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Periodic Fever Syndrome Market Share by Type (2015-2020)
Table 57. Japan Periodic Fever Syndrome Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Periodic Fever Syndrome Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Periodic Fever Syndrome Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Periodic Fever Syndrome Market Share (2019-2020)
Table 61. Southeast Asia Periodic Fever Syndrome Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Periodic Fever Syndrome Market Share by Type (2015-2020)
Table 63. Southeast Asia Periodic Fever Syndrome Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Periodic Fever Syndrome Market Share by Application (2015-2020)
Table 65. India Key Players Periodic Fever Syndrome Revenue (2019-2020) (Million US$)
Table 66. India Key Players Periodic Fever Syndrome Market Share (2019-2020)
Table 67. India Periodic Fever Syndrome Market Size by Type (2015-2020) (Million US$)
Table 68. India Periodic Fever Syndrome Market Share by Type (2015-2020)
Table 69. India Periodic Fever Syndrome Market Size by Application (2015-2020) (Million US$)
Table 70. India Periodic Fever Syndrome Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Periodic Fever Syndrome Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Periodic Fever Syndrome Market Share (2019-2020)
Table 73. Central & South America Periodic Fever Syndrome Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Periodic Fever Syndrome Market Share by Type (2015-2020)
Table 75. Central & South America Periodic Fever Syndrome Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Periodic Fever Syndrome Market Share by Application (2015-2020)
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Product
Table 80. Novartis Revenue in Periodic Fever Syndrome Business (2015-2020) (Million US$)
Table 81. Novartis Recent Development
Table 82. Simvastatin Company Details
Table 83. Simvastatin Business Overview
Table 84. Simvastatin Product
Table 85. Simvastatin Revenue in Periodic Fever Syndrome Business (2015-2020) (Million US$)
Table 86. Simvastatin Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Product
Table 90. Merck Revenue in Periodic Fever Syndrome Business (2015-2020) (Million US$)
Table 91. Merck Recent Development
Table 92. Swedish Orphan Biovitrum Company Details
Table 93. Swedish Orphan Biovitrum Business Overview
Table 94. Swedish Orphan Biovitrum Product
Table 95. Swedish Orphan Biovitrum Revenue in Periodic Fever Syndrome Business (2015-2020) (Million US$)
Table 96. Swedish Orphan Biovitrum Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Periodic Fever Syndrome Market Share by Type: 2020 VS 2026
Figure 2. Hyperimmunoglobulinemia D Syndrome Features
Figure 3. Familial Mediterranean Fever Syndrome Features
Figure 4. TNF Receptor-Associated Periodic Syndrome Features
Figure 5. Cryopyrin-Associated Periodic Syndrome Features
Figure 6. Others Features
Figure 7. Global Periodic Fever Syndrome Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Periodic Fever Syndrome Report Years Considered
Figure 11. Global Periodic Fever Syndrome Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Periodic Fever Syndrome Market Share by Regions: 2020 VS 2026
Figure 13. Global Periodic Fever Syndrome Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Periodic Fever Syndrome Market Share by Players in 2019
Figure 16. Global Top Periodic Fever Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Periodic Fever Syndrome as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Periodic Fever Syndrome Revenue in 2019
Figure 18. North America Periodic Fever Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Periodic Fever Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Periodic Fever Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Periodic Fever Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Periodic Fever Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Periodic Fever Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Periodic Fever Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介
  • Q熱の世界市場（～2026年）
    Global Q Fever Market Size, Status and Forecast 2020-2026
    MRC2-11QY04425 2020年11月20日 95Pages
    当調査資料はQ熱のグローバル市場について調査・分析したレポートです。種類別（急性Q熱、慢性Q熱）市場規模、用途別（病院・診療所、診断センター、外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア...
  • リウマチ熱治療の世界市場（～2026年）
    Global Rheumatic Fever Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04513 2020年11月20日 96Pages
    当調査資料はリウマチ熱治療のグローバル市場について調査・分析したレポートです。種類別（抗生物質、抗炎症薬、抗けいれん薬、その他）市場規模、用途別（病院、診療所、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...
  • マールブルグ出血熱治療薬の世界市場（～2026年）
    Global Marburg Hemorrhagic Fever Drug Market Insights and Forecast to 2026
    MRC2-11QY07470 2020年11月20日 112Pages
    当調査資料はマールブルグ出血熱治療薬のグローバル市場について調査・分析したレポートです。種類別（マールブルグワクチン、AVI-7288、TKM-マールブルグ、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...
  • 痛み・発熱緩和薬の世界市場（～2026年）
    Global Pain and Fever Relief Drugs Market Insights and Forecast to 2026
    MRC2-11QY08666 2020年11月25日 110Pages
    当調査資料は痛み・発熱緩和薬のグローバル市場について調査・分析したレポートです。種類別（アスピリン、パラセタモール、ナプロキセン、イブプロフェン、ジクロフェン酸、メタミゾールナトリウム）市場規模、用途別（病院、クリニック、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラ...
  • チクングニア熱治療薬の世界市場（～2026年）
    Global Chikungunya Fever Drugs Market Insights and Forecast to 2026
    MRC2-11QY00189 2020年11月20日 116Pages
    当調査資料はチクングニア熱治療薬のグローバル市場について調査・分析したレポートです。種類別（チクングニア熱ワクチン、モノクローナル抗体、ポリ硫酸ペントサンナトリウム、合成ペプチド、その他）市場規模、用途別（クリニック、研究機関、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...
  • ドラベ症候群治療の世界市場（～2026年）
    Global Dravet Syndrome Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11711 2020年11月25日 97Pages
    当調査資料はドラベ症候群治療のグローバル市場について調査・分析したレポートです。種類別（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））市場規模、用途別（病院薬局、小売薬局、Eコマース、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...
  • 吸収不良症候群の世界市場（～2026年）
    Global Malabsorption Syndrome Market Size, Status and Forecast 2020-2026
    MRC2-11QY12575 2020年11月25日 93Pages
    当調査資料は吸収不良症候群のグローバル市場について調査・分析したレポートです。種類別（乳糖不耐症、嚢胞性線維症、ウィップル病、寄生虫症、熱帯性スプルー、腸障害）市場規模、用途別（製薬会社、病院、栄養クリニック、学術研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...
  • チャーグ・ストラウス症候群の世界市場（～2026年）
    Global Churg Strauss Syndrome Market Size, Status and Forecast 2020-2026
    MRC2-11QY11375 2020年11月25日 95Pages
    当調査資料はチャーグ・ストラウス症候群のグローバル市場について調査・分析したレポートです。種類別（生物製剤、免疫グロブリン、ワクチン、ステロイド、その他）市場規模、用途別（研究所、病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア...
  • 多嚢胞性卵巣症候群治療の世界市場（～2026年）
    Global Polycystic Ovarian Syndrome Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04319 2020年11月20日 98Pages
    当調査資料は多嚢胞性卵巣症候群治療のグローバル市場について調査・分析したレポートです。種類別（経口避妊薬、インスリン増感剤、抗うつ剤、オルニチン、デカルボキシラーゼ阻害剤、アロマターゼ阻害剤およびSERM、利尿剤）市場規模、用途別（病院薬局、ドラッグストア、Eコマース、不妊治療クリニック）市場規模、...
  • クッシング症候群治療の世界市場（～2026年）
    Global Cushing's Syndrome Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11542 2020年11月25日 96Pages
    当調査資料はクッシング症候群治療のグローバル市場について調査・分析したレポートです。種類別（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...
  • バーター症候群治療薬の世界市場（～2026年）バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…
  • バーター症候群治療の世界市場（～2026年）バーター症候群治療の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…
  • クッシング症候群治療の世界市場（～2026年）クッシング症候群治療の世界市場（～2026年） Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. In terms of…
  • チャーグ・ストラウス症候群の世界市場（～2026年）チャーグ・ストラウス症候群の世界市場（～2026年） Churg Strauss syndrome is a disorder that causes inflammation in blood vessels. This restricts the blood flow to vital organs and tissues. Sometimes it leads to permanent damage of tissues. This condition is also known as eosinophilic granulomatosis with polyangiitis. Asthma is the most common sign …
  • ドラベ症候群治療の世界市場（～2026年）ドラベ症候群治療の世界市場（～2026年） Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells. Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include …